Detalles de la búsqueda
1.
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.
Blood;
143(2): 178-182, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37963262
2.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood;
2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728380
3.
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
Br J Haematol;
204(4): 1159-1175, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390784
4.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol;
2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577874
5.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Lancet;
401(10373): 269-280, 2023 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709073
6.
Hydroxycarbamide effects on DNA methylation and gene expression in myeloproliferative neoplasms.
Genome Res;
31(8): 1381-1394, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244229
7.
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica;
2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546696
8.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
9.
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Am J Hematol;
99(2): 203-215, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009469
10.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Am J Hematol;
99(5): 993-996, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385579
11.
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies.
Value Health;
27(5): 607-613, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38311180
12.
Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?
Br J Haematol;
203(2): 169-181, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37527977
13.
Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia.
Haematologica;
108(6): 1555-1566, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36700403
14.
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol;
98(4): 628-638, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606718
15.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol;
98(1): 112-121, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266607
16.
How I manage myeloproliferative neoplasm-unclassifiable: Practical approaches for 2022 and beyond.
Br J Haematol;
197(4): 407-416, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35191542
17.
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype.
Br J Haematol;
198(6): 1011-1015, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802024
18.
Current and future status of JAK inhibitors.
Lancet;
398(10302): 803-816, 2021 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34454676
19.
Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis.
Am J Hematol;
97(11): 1464-1477, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802782
20.
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Br J Haematol;
193(4): 792-797, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751548